Risk of multiple drug-drug interactions (DDIs) in HCV patients receiving pangenotypic DAAs (pDAAs): A complex drug interaction scenario first time evaluated in German patients

被引:0
|
作者
Umland, Tim [1 ]
Hintz, Andreas [1 ]
Niess, Gero [2 ]
Guendogdu, Mehtap [2 ]
Tacke, Frank [3 ]
机构
[1] Alexander Apotheke, Hamburg, Germany
[2] Gilead Sci GmbH, Planegg, Germany
[3] Charite Campus Mitte, Med Klin MS Hepatol & Gastroenterol, Berlin, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-377
引用
收藏
页码:S793 / S793
页数:1
相关论文
共 50 条
  • [1] IMPACT OF POLYPHARMACY AND AGING ON THE RISK OF MULTIPLE DRUG-DRUG INTERACTIONS (DDIS) IN HCV PATIENTS TREATED WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (PDAA)
    Mangia, Alessandra
    Toniutto, Pierluigi
    Coppola, Nicola
    Ancona, Domenica Daniela
    Andretta, Margherita
    Bartolini, Fausto
    Ferrante, Fulvio
    Lupi, Alessandro
    Palcic, Stefano
    Rizzi, Francesca Vittoria
    Re, Davide
    Nieto, Gema Alvarez
    Hernandez, Candido
    Perrone, Valentina
    Degli Esposti, Luca
    Fagiuoli, Stefano
    HEPATOLOGY, 2021, 74 : 566A - 567A
  • [2] DRUG-DRUG INTERACTIONS (DDIS) IN ITALIAN PATIENTS WITH CHRONIC HEPATITIS C (HCV) TREATED WITH PANGENOTYPIC DIRECT ACTING AGENTS (PDAAS): FOCUS ON CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEM COMEDICATIONS
    Mangia, Alessandra
    Scaglione, Francesco
    Toniutto, Pierluigi
    Pirisi, Mario
    Coppola, Nicola
    Di Perri, Giovanni
    Perrone, Valentina
    Esposti, Luca Degli
    Nieto, Gema Alvarez
    Calabrese, Stefano
    Hernandez, Candido
    Fagiuoli, Stefano
    HEPATOLOGY, 2020, 72 : 529A - 530A
  • [3] Frequency and impact of potential multiple drug-drug interactions (DDIs) associated with pangenotypic direct-acting antivirals in patients receiving opioid substitution therapy
    Umland, Tim
    Hintz, Andreas
    Niess, Gero
    Guendogdu, Mehtap
    Tacke, Frank
    JOURNAL OF HEPATOLOGY, 2021, 75 : S794 - S794
  • [4] DRUG-DRUG INTERACTIONS (DDIS) WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (DAAS) IN PATIENTS WITH HEPATITIS C; UNDERSTANDING THE POPULATIONS AT RISK AND REAL-WORLD CARE MANAGEMENT
    Curry, Michael P.
    Tsai, Naoky C. S.
    Bacon, Bruce R.
    Flamm, Steven L.
    Younossi, Zobair M.
    Milligan, Scott
    Wick, Nicole
    Afdhal, Nezam H.
    HEPATOLOGY, 2019, 70 : 903A - 904A
  • [5] Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management
    Curry, Michael
    Tsai, Naoky
    Bacon, Bruce
    Flamm, Steven
    Younossi, Zobair
    Milligan, Scott
    Wick, Nicole
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S355 - S356
  • [6] Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
    Fagiuoli, Stefano
    Toniutto, Pierluigi
    Coppola, Nicola
    Ancona, Domenica Daniela
    Andretta, Margherita
    Bartolini, Fausto
    Ferrante, Fulvio
    Lupi, Alessandro
    Palcic, Stefano
    Rizzi, Francesca Vittoria
    Re, Davide
    Nieto, Gema Alvarez
    Hernandez, Candido
    Frigerio, Francesca
    Perrone, Valentina
    Degli Esposti, Luca
    Mangia, Alessandra
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 57 - 65
  • [7] DRUG-DRUG INTERACTIONS (DDIS) UNDER HCV THERAPY: ANTIPSYCHOTIC DRUGS IN ADDICTED PATIENTS AND PATIENTS ON OPIOID SUBSTITUTION THERAPY (OST)
    Tacke, Frank
    Umland, Tim
    Hintz, Andreas
    Moerner, Anika
    Guendogdu, Mehtap
    HEPATOLOGY, 2020, 72 : 551A - 552A
  • [8] Drug-drug interactions in patients receiving tyrosine kinase inhibitors
    Keller, Kristine L.
    Franquiz, Miguel J.
    Duffy, Alison P.
    Trovato, James A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (02) : 110 - 115
  • [9] Text mining to identify drug-drug interactions (DDIs) in elderly patients admitted to emergency department
    Pujade, Iris
    Duthoit, Perrine
    Evrard, Gregoire
    Bel-Letoile, Alicia
    Goehrs, Clement
    Jouhet, Vianney
    Cossin, Sebastien
    Pariente, Antoine
    Thiessard, Frantz
    Salvo, Francesco
    Letinier, Louis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 400 - 400
  • [10] DRUG DRUG INTERACTIONS BETWEEN ANTIPSYCHOTICS AND PANGENOTYPIC DAA IN PATIENTS RECEIVING OPIOID SUBSTITUTE THERAPY
    Chang, Chihhao
    Chang, Yea-Yuan
    Wei, Han-Ting
    Wang, Chien-Chun
    HEPATOLOGY, 2023, 78 : S716 - S717